Radioimmunotherapy deemed safe and effective for lymphoma patients Science Codex According to data published in the July issue of The Journal of Nuclear Medicine, the use of 177Lu-DOTA-rituximab as a radioimmunotherapy results in a high rate of tumor response while using less radiation than current therapies. "Twelve years ago ... |
